Launch of New Product Ranges by Amrutanjan Health Care Limited

Amrutanjan Health Care Limited has officially announced the launch of a diverse new range of products across the Personal Care, Wound Care, and Pain Management categories. This strategic move, detailed in their regulatory filing dated April 17, 2026, aims to leverage the company’s trusted brand equity while expanding into high-growth grooming and healthcare segments.

The launch includes a significant entry into the razors category with the introduction of Comfy Close & Clean and Comfy Silky Smooth for women, alongside the Smoothe’ Xpress range for men. In the wound care segment, the company introduced Amrutanjan Plastry, a range of medicated antiseptic plasters available in regular and wash-proof variants. Furthermore, the pain management portfolio has been strengthened with Amrutanjan Ortho Pain Relief + Oil, a clinically proven formulation designed to offer up to 66% pain reduction within eight weeks of use. These products are primarily targeted at the domestic market.

Amrutanjan Health Care Limited, founded in 1893, is a pioneer in the Indian healthcare space, best known for its iconic Ayurvedic pain relief balms. Beyond its core pain management segment, the company has diversified into women’s hygiene (Comfy pads) and beverages (Fruitnik). In recent 2025 updates, the company successfully managed its regulatory filings, including the issuance of RTA certificates and notifications regarding board meetings for dividend declarations. Notably, in October 2025, the company received an order under the CGST/IGST Act, which it intends to contest through appropriate legal channels.

For the quarter ended December 2025, Amrutanjan Health Care reported a revenue of ₹145.16 Crores, representing a 14.2% year-on-year (YoY) growth compared to ₹127.11 Crores in the same period of 2024. The standalone net profit for the same quarter rose slightly to ₹19.45 Crores, up from ₹19.25 Crores in the previous year. On a quarter-on-quarter (QoQ) basis, the company saw a significant 39.33% jump in net profits compared to the September 2025 quarter. Prominent institutional investors in the company as of 2025 include DSP BlackRock Investment Managers Pvt. Ltd., holding a significant 5.07% stake.